Superhouse Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: September 18, 2025, 10:15 pm

Quick Insight

Superhouse Ltd, operating in the leather/synthetic products industry, currently trades at a price of 149 with a market cap of 164 Cr. Despite a high P/E ratio of 54.2, the company's ROE stands at 1.19% and ROCE at 3.90%, indicating relatively low returns on equity and capital employed. With an OPM of 4.37%, the company faces challenges in maintaining profitability. The low P/BV of 0.47x suggests undervaluation, while the ICR of 3.16x indicates a healthy interest coverage ratio. However, with a CCC of 237 days, liquidity management may be a concern. Investors should carefully evaluate these metrics before considering an investment in Superhouse Ltd.

Competitors of Superhouse Ltd

All Competitor Stocks of Superhouse Ltd

Quarterly Result

Last Updated: August 20, 2025, 2:55 am

Below is a detailed analysis of the quarterly data for Superhouse Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:

• For Sales, as of Jun 2025, the value is 162.68 Cr.. The value appears to be declining and may need further review. It has decreased from 176.04 Cr. (Mar 2025) to 162.68 Cr., marking a decrease of 13.36 Cr..
• For Expenses, as of Jun 2025, the value is 155.57 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 166.36 Cr. (Mar 2025) to 155.57 Cr., marking a decrease of 10.79 Cr..
• For Operating Profit, as of Jun 2025, the value is 7.11 Cr.. The value appears to be declining and may need further review. It has decreased from 9.68 Cr. (Mar 2025) to 7.11 Cr., marking a decrease of 2.57 Cr..
• For OPM %, as of Jun 2025, the value is 4.37%. The value appears to be declining and may need further review. It has decreased from 5.50% (Mar 2025) to 4.37%, marking a decrease of 1.13%.
• For Other Income, as of Jun 2025, the value is 4.12 Cr.. The value appears strong and on an upward trend. It has increased from 1.62 Cr. (Mar 2025) to 4.12 Cr., marking an increase of 2.50 Cr..
• For Interest, as of Jun 2025, the value is 5.77 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 6.68 Cr. (Mar 2025) to 5.77 Cr., marking a decrease of 0.91 Cr..
• For Depreciation, as of Jun 2025, the value is 4.71 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 5.21 Cr. (Mar 2025) to 4.71 Cr., marking a decrease of 0.50 Cr..
• For Profit before tax, as of Jun 2025, the value is 0.75 Cr.. The value appears strong and on an upward trend. It has increased from -0.59 Cr. (Mar 2025) to 0.75 Cr., marking an increase of 1.34 Cr..
• For Tax %, as of Jun 2025, the value is 233.33%. The value appears to be increasing, which may not be favorable. It has increased from -44.07% (Mar 2025) to 233.33%, marking an increase of 277.40%.
• For Net Profit, as of Jun 2025, the value is -0.32 Cr.. The value appears to be declining and may need further review. It has decreased from 0.66 Cr. (Mar 2025) to -0.32 Cr., marking a decrease of 0.98 Cr..
• For EPS in Rs, as of Jun 2025, the value is -0.25. The value appears to be declining and may need further review. It has decreased from 0.81 (Mar 2025) to -0.25, marking a decrease of 1.06.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: July 22, 2025, 2:55 pm

Growth

Last Updated: September 5, 2025, 1:36 pm

Balance Sheet

Last Updated: September 10, 2025, 2:35 pm

Below is a detailed analysis of the balance sheet data for Superhouse Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Equity Capital, as of Mar 2025, the value is 11.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 11.00 Cr..
• For Reserves, as of Mar 2025, the value is 446.00 Cr.. The value appears strong and on an upward trend. It has increased from 438.00 Cr. (Mar 2024) to 446.00 Cr., marking an increase of 8.00 Cr..
• For Borrowings, as of Mar 2025, the value is 211.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 204.00 Cr. (Mar 2024) to 211.00 Cr., marking an increase of 7.00 Cr..
• For Other Liabilities, as of Mar 2025, the value is 188.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 176.00 Cr. (Mar 2024) to 188.00 Cr., marking an increase of 12.00 Cr..
• For Total Liabilities, as of Mar 2025, the value is 856.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 828.00 Cr. (Mar 2024) to 856.00 Cr., marking an increase of 28.00 Cr..
• For Fixed Assets, as of Mar 2025, the value is 261.00 Cr.. The value appears to be declining and may need further review. It has decreased from 267.00 Cr. (Mar 2024) to 261.00 Cr., marking a decrease of 6.00 Cr..
• For CWIP, as of Mar 2025, the value is 2.00 Cr.. The value appears to be declining and may need further review. It has decreased from 6.00 Cr. (Mar 2024) to 2.00 Cr., marking a decrease of 4.00 Cr..
• For Investments, as of Mar 2025, the value is 30.00 Cr.. The value appears strong and on an upward trend. It has increased from 29.00 Cr. (Mar 2024) to 30.00 Cr., marking an increase of 1.00 Cr..
• For Other Assets, as of Mar 2025, the value is 562.00 Cr.. The value appears strong and on an upward trend. It has increased from 526.00 Cr. (Mar 2024) to 562.00 Cr., marking an increase of 36.00 Cr..
• For Total Assets, as of Mar 2025, the value is 856.00 Cr.. The value appears strong and on an upward trend. It has increased from 828.00 Cr. (Mar 2024) to 856.00 Cr., marking an increase of 28.00 Cr..

Notably, the Reserves (446.00 Cr.) exceed the Borrowings (211.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Cash Flow

Free Cash Flow

Share Holding Pattern

Key Financial Ratios

After reviewing the key financial ratios for Superhouse Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 24, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 23) which recorded 10.00.
• For Basic EPS (Rs.), as of Mar 24, the value is 11.61. This value is within the healthy range. It has decreased from 24.04 (Mar 23) to 11.61, marking a decrease of 12.43.
• For Diluted EPS (Rs.), as of Mar 24, the value is 11.61. This value is within the healthy range. It has decreased from 24.04 (Mar 23) to 11.61, marking a decrease of 12.43.
• For Cash EPS (Rs.), as of Mar 24, the value is 27.78. This value is within the healthy range. It has decreased from 39.85 (Mar 23) to 27.78, marking a decrease of 12.07.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 417.36. It has increased from 411.26 (Mar 23) to 417.36, marking an increase of 6.10.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 417.36. It has increased from 411.26 (Mar 23) to 417.36, marking an increase of 6.10.
• For Revenue From Operations / Share (Rs.), as of Mar 24, the value is 618.91. It has decreased from 694.78 (Mar 23) to 618.91, marking a decrease of 75.87.
• For PBDIT / Share (Rs.), as of Mar 24, the value is 45.51. This value is within the healthy range. It has decreased from 61.07 (Mar 23) to 45.51, marking a decrease of 15.56.
• For PBIT / Share (Rs.), as of Mar 24, the value is 28.64. This value is within the healthy range. It has decreased from 46.55 (Mar 23) to 28.64, marking a decrease of 17.91.
• For PBT / Share (Rs.), as of Mar 24, the value is 14.24. This value is within the healthy range. It has decreased from 33.68 (Mar 23) to 14.24, marking a decrease of 19.44.
• For Net Profit / Share (Rs.), as of Mar 24, the value is 10.91. This value is within the healthy range. It has decreased from 25.33 (Mar 23) to 10.91, marking a decrease of 14.42.
• For NP After MI And SOA / Share (Rs.), as of Mar 24, the value is 11.61. This value is within the healthy range. It has decreased from 25.33 (Mar 23) to 11.61, marking a decrease of 13.72.
• For PBDIT Margin (%), as of Mar 24, the value is 7.35. This value is below the healthy minimum of 10. It has decreased from 8.79 (Mar 23) to 7.35, marking a decrease of 1.44.
• For PBIT Margin (%), as of Mar 24, the value is 4.62. This value is below the healthy minimum of 10. It has decreased from 6.70 (Mar 23) to 4.62, marking a decrease of 2.08.
• For PBT Margin (%), as of Mar 24, the value is 2.30. This value is below the healthy minimum of 10. It has decreased from 4.84 (Mar 23) to 2.30, marking a decrease of 2.54.
• For Net Profit Margin (%), as of Mar 24, the value is 1.76. This value is below the healthy minimum of 5. It has decreased from 3.64 (Mar 23) to 1.76, marking a decrease of 1.88.
• For NP After MI And SOA Margin (%), as of Mar 24, the value is 1.87. This value is below the healthy minimum of 8. It has decreased from 3.64 (Mar 23) to 1.87, marking a decrease of 1.77.
• For Return on Networth / Equity (%), as of Mar 24, the value is 2.78. This value is below the healthy minimum of 15. It has decreased from 6.37 (Mar 23) to 2.78, marking a decrease of 3.59.
• For Return on Capital Employeed (%), as of Mar 24, the value is 5.99. This value is below the healthy minimum of 10. It has decreased from 10.53 (Mar 23) to 5.99, marking a decrease of 4.54.
• For Return On Assets (%), as of Mar 24, the value is 1.49. This value is below the healthy minimum of 5. It has decreased from 3.32 (Mar 23) to 1.49, marking a decrease of 1.83.
• For Long Term Debt / Equity (X), as of Mar 24, the value is 0.05. This value is below the healthy minimum of 0.2. It has increased from 0.03 (Mar 23) to 0.05, marking an increase of 0.02.
• For Total Debt / Equity (X), as of Mar 24, the value is 0.45. This value is within the healthy range. It has increased from 0.43 (Mar 23) to 0.45, marking an increase of 0.02.
• For Asset Turnover Ratio (%), as of Mar 24, the value is 0.79. It has decreased from 0.93 (Mar 23) to 0.79, marking a decrease of 0.14.
• For Current Ratio (X), as of Mar 24, the value is 1.62. This value is within the healthy range. It has increased from 1.53 (Mar 23) to 1.62, marking an increase of 0.09.
• For Quick Ratio (X), as of Mar 24, the value is 0.86. This value is below the healthy minimum of 1. It has increased from 0.78 (Mar 23) to 0.86, marking an increase of 0.08.
• For Inventory Turnover Ratio (X), as of Mar 24, the value is 1.04. This value is below the healthy minimum of 4. It has decreased from 1.37 (Mar 23) to 1.04, marking a decrease of 0.33.
• For Dividend Payout Ratio (NP) (%), as of Mar 24, the value is 9.43. This value is below the healthy minimum of 20. It has increased from 4.21 (Mar 23) to 9.43, marking an increase of 5.22.
• For Dividend Payout Ratio (CP) (%), as of Mar 24, the value is 3.84. This value is below the healthy minimum of 20. It has increased from 2.68 (Mar 23) to 3.84, marking an increase of 1.16.
• For Earning Retention Ratio (%), as of Mar 24, the value is 90.57. This value exceeds the healthy maximum of 70. It has decreased from 95.79 (Mar 23) to 90.57, marking a decrease of 5.22.
• For Cash Earning Retention Ratio (%), as of Mar 24, the value is 96.16. This value exceeds the healthy maximum of 70. It has decreased from 97.32 (Mar 23) to 96.16, marking a decrease of 1.16.
• For Interest Coverage Ratio (X), as of Mar 24, the value is 3.16. This value is within the healthy range. It has decreased from 4.74 (Mar 23) to 3.16, marking a decrease of 1.58.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 24, the value is 1.76. This value is below the healthy minimum of 3. It has decreased from 2.97 (Mar 23) to 1.76, marking a decrease of 1.21.
• For Enterprise Value (Cr.), as of Mar 24, the value is 371.75. It has decreased from 397.22 (Mar 23) to 371.75, marking a decrease of 25.47.
• For EV / Net Operating Revenue (X), as of Mar 24, the value is 0.55. This value is below the healthy minimum of 1. It has increased from 0.51 (Mar 23) to 0.55, marking an increase of 0.04.
• For EV / EBITDA (X), as of Mar 24, the value is 7.60. This value is within the healthy range. It has increased from 5.90 (Mar 23) to 7.60, marking an increase of 1.70.
• For MarketCap / Net Operating Revenue (X), as of Mar 24, the value is 0.31. This value is below the healthy minimum of 1. It has decreased from 0.33 (Mar 23) to 0.31, marking a decrease of 0.02.
• For Retention Ratios (%), as of Mar 24, the value is 90.56. This value exceeds the healthy maximum of 70. It has decreased from 95.78 (Mar 23) to 90.56, marking a decrease of 5.22.
• For Price / BV (X), as of Mar 24, the value is 0.47. This value is below the healthy minimum of 1. It has decreased from 0.59 (Mar 23) to 0.47, marking a decrease of 0.12.
• For Price / Net Operating Revenue (X), as of Mar 24, the value is 0.31. This value is below the healthy minimum of 1. It has decreased from 0.33 (Mar 23) to 0.31, marking a decrease of 0.02.
• For EarningsYield, as of Mar 24, the value is 0.05. This value is below the healthy minimum of 5. It has decreased from 0.10 (Mar 23) to 0.05, marking a decrease of 0.05.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness